(4-chlorophenyl)-[4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]piperazin-1-yl]methanone;2-(4-chlorophenyl)-3-(morpholin-4-ylmethyl)imidazo[1,2-a]pyridine-6-carbonitrile;[4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]piperazin-1-yl]-pyrazin-2-ylmethanone;1-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]piperidine-4-carboxylic acid;4-[[2-(4-chlorophenyl)-6-(2H-tetrazol-5-yl)imidazo[1,2-a]pyridin-3-yl]methyl]morpholine
C124H110Cl6N24O6 — CID 158349457
Data last refreshed: (MolForge compound catalog, from PubChem)
About (4-chlorophenyl)-[4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]piperazin-1-yl]methanone;2-(4-chlorophenyl)-3-(morpholin-4-ylmethyl)imidazo[1,2-a]pyridine-6-carbonitrile;[4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]piperazin-1-yl]-pyrazin-2-ylmethanone;1-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]piperidine-4-carboxylic acid;4-[[2-(4-chlorophenyl)-6-(2H-tetrazol-5-yl)imidazo[1,2-a]pyridin-3-yl]methyl]morpholine
(4-chlorophenyl)-[4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]piperazin-1-yl]methanone;2-(4-chlorophenyl)-3-(morpholin-4-ylmethyl)imidazo[1,2-a]pyridine-6-carbonitrile;[4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]piperazin-1-yl]-pyrazin-2-ylmethanone;1-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]piperidine-4-carboxylic acid;4-[[2-(4-chlorophenyl)-6-(2H-tetrazol-5-yl)imidazo[1,2-a]pyridin-3-yl]methyl]morpholine (PubChem CID 158349457) has the molecular formula C124H110Cl6N24O6 and a molecular weight of 2245.12 g/mol. Its IUPAC name is (4-chlorophenyl)-[4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]piperazin-1-yl]methanone;2-(4-chlorophenyl)-3-(morpholin-4-ylmethyl)imidazo[1,2-a]pyridine-6-carbonitrile;[4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]piperazin-1-yl]-pyrazin-2-ylmethanone;1-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]piperidine-4-carboxylic acid;4-[[2-(4-chlorophenyl)-6-(2H-tetrazol-5-yl)imidazo[1,2-a]pyridin-3-yl]methyl]morpholine.
Molecular Properties
| Compound Name | (4-chlorophenyl)-[4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]piperazin-1-yl]methanone;2-(4-chlorophenyl)-3-(morpholin-4-ylmethyl)imidazo[1,2-a]pyridine-6-carbonitrile;[4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]piperazin-1-yl]-pyrazin-2-ylmethanone;1-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]piperidine-4-carboxylic acid;4-[[2-(4-chlorophenyl)-6-(2H-tetrazol-5-yl)imidazo[1,2-a]pyridin-3-yl]methyl]morpholine |
|---|---|
| PubChem CID | 158349457 |
| Molecular Formula | C124H110Cl6N24O6 |
| Molecular Weight | 2245.12 g/mol |
| Exact Mass | 2240.72 |
| IUPAC Name | (4-chlorophenyl)-[4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]piperazin-1-yl]methanone;2-(4-chlorophenyl)-3-(morpholin-4-ylmethyl)imidazo[1,2-a]pyridine-6-carbonitrile;[4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]piperazin-1-yl]-pyrazin-2-ylmethanone;1-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]piperidine-4-carboxylic acid;4-[[2-(4-chlorophenyl)-6-(2H-tetrazol-5-yl)imidazo[1,2-a]pyridin-3-yl]methyl]morpholine |
| SMILES | Clc1ccc(-c2nc3ccc(-c4nn[nH]n4)cn3c2CN2CCOCC2)cc1.N#Cc1ccc2nc(-c3ccc(Cl)cc3)c(CN3CCOCC3)n2c1.O=C(O)C1CCN(Cc2c(-c3ccc(Cl)cc3)nc3ccc(-c4ccccc4)cn23)CC1.O=C(c1ccc(Cl)cc1)N1CCN(Cc2c(-c3ccc(Cl)cc3)nc3ccc(-c4ccccc4)cn23)CC1.O=C(c1cnccn1)N1CCN(Cc2c(-c3ccc(Cl)cc3)nc3ccc(-c4ccccc4)cn23)CC1 |
| InChI | InChI=1S/C31H26Cl2N4O.C29H25ClN6O.C26H24ClN3O2.C19H18ClN7O.C19H17ClN4O/c32-26-11-6-23(7-12-26)30-28(37-20-25(10-15-29(37)34-30)22-4-2-1-3-5-22)21-35-16-18-36(19-17-35)31(38)24-8-13-27(33)14-9-24;30-24-9-6-22(7-10-24)28-26(36-19-23(8-11-27(36)33-28)21-4-2-1-3-5-21)20-34-14-16-35(17-15-34)29(37)25-18-31-12-13-32-25;27-22-9-6-19(7-10-22)25-23(17-29-14-12-20(13-15-29)26(31)32)30-16-21(8-11-24(30)28-25)18-4-2-1-3-5-18;20-15-4-1-13(2-5-15)18-16(12-26-7-9-28-10-8-26)27-11-14(3-6-17(27)21-18)19-22-24-25-23-19;20-16-4-2-15(3-5-16)19-17(13-23-7-9-25-10-8-23)24-12-14(11-21)1-6-18(24)22-19/h1-15,20H,16-19,21H2;1-13,18-19H,14-17,20H2;1-11,16,20H,12-15,17H2,(H,31,32);1-6,11H,7-10,12H2,(H,22,23,24,25);1-6,12H,7-10,13H2 |
| InChIKey | GSDGDCNNKYEPEN-UHFFFAOYSA-N |
| XLogP | 23.65 |
| TPSA | 303.11 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 26 |
| Rotatable Bonds | 22 |
| Heavy Atoms | 160 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2245.12 |
| LogP ≤ 5 | 23.65 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 26 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158349457 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.